KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants.
Adolescent
Adult
Child
Child, Preschool
Chromosome Deletion
Developmental Disabilities
/ genetics
Exome
/ genetics
Female
Genetic Association Studies
Genotype
Histone Acetyltransferases
/ genetics
Humans
Infant
Intellectual Disability
/ genetics
Male
Microcephaly
/ genetics
Mutation
Phenotype
Protein Isoforms
/ genetics
Young Adult
KAT6A syndrome; chromatin modifiers; intellectual disability
genetic diagnosis
phenotypic spectrum
Journal
Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
09
03
2018
accepted:
26
07
2018
pubmed:
25
9
2018
medline:
19
6
2019
entrez:
25
9
2018
Statut:
ppublish
Résumé
Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. Within 2 years, the number of patients identified with pathogenic KAT6A variants has rapidly expanded and the full extent and variability of the clinical phenotype has not been reported. We obtained data for patients with KAT6A pathogenic variants through three sources: treating clinicians, an online family survey distributed through social media, and a literature review. We identified 52 unreported cases, bringing the total number of published cases to 76. Our results expand the genotypic spectrum of pathogenic variants to include missense and splicing mutations. We functionally validated a pathogenic splice-site variant and identified a likely hotspot location for de novo missense variants. The majority of clinical features in KAT6A syndrome have highly variable penetrance. For core features such as intellectual disability, speech delay, microcephaly, cardiac anomalies, and gastrointestinal complications, genotype- phenotype correlations show that late-truncating pathogenic variants (exons 16-17) are significantly more prevalent. We highlight novel associations, including an increased risk of gastrointestinal obstruction. Our data expand the genotypic and phenotypic spectrum for individuals with genetic pathogenic variants in KAT6A and we outline appropriate clinical management.
Identifiants
pubmed: 30245513
doi: 10.1038/s41436-018-0259-2
pii: S1098-3600(21)00958-8
pmc: PMC6634310
mid: NIHMS1040041
doi:
Substances chimiques
Protein Isoforms
0
Histone Acetyltransferases
EC 2.3.1.48
KAT6A protein, human
EC 2.3.1.48
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
850-860Subventions
Organisme : Department of Health
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : U54 HD086984
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIH HHS
ID : DP5 OD024579
Pays : United States
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom
Commentaires et corrections
Type : ErratumIn
Références
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9585-90
pubmed: 24979783
PLoS Curr. 2014 Oct 17;6:
pubmed: 25635234
J Pediatr Genet. 2017 Jun;6(2):77-83
pubmed: 28496994
Am J Hum Genet. 2017 Jan 5;100(1):91-104
pubmed: 27939640
Am J Med Genet A. 2013 Apr;161A(4):884-8
pubmed: 23436491
Am J Med Genet A. 2017 Jan;173(1):62-71
pubmed: 27615324
Hum Genome Var. 2017;4:17045
pubmed: 31754438
JAMA. 2014 Nov 12;312(18):1880-7
pubmed: 25326637
Clin Transl Allergy. 2017 Jun 22;7:19
pubmed: 28649320
Oncogene. 2007 Aug 13;26(37):5395-407
pubmed: 17694081
Am J Hum Genet. 2017 Jan 5;100(1):105-116
pubmed: 27939639
Cell Mol Life Sci. 2011 Apr;68(7):1147-56
pubmed: 21132344
Am J Med Genet A. 2016 Jul;170(7):1791-8
pubmed: 27133397
Biochim Biophys Acta. 2015 Aug;1853(8):1818-26
pubmed: 25920810
Cell Rep. 2016 Sep 20;16(12):3311-3321
pubmed: 27653692
Am J Med Genet A. 2017 Sep;173(9):2562-2565
pubmed: 28636259
Dev Cell. 2009 Nov;17(5):674-86
pubmed: 19922872
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Genome Biol. 2016 Nov 17;17(1):233
pubmed: 27855690
N Engl J Med. 2017 Jan 5;376(1):21-31
pubmed: 27959697
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Genes Dev. 2006 May 1;20(9):1175-86
pubmed: 16651658
Am J Hum Genet. 2015 Mar 5;96(3):507-13
pubmed: 25728777
Am J Hum Genet. 2011 Nov 11;89(5):675-81
pubmed: 22077973
Hum Mutat. 2012 Nov;33(11):1520-5
pubmed: 22715153
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Lancet. 2015 Apr 4;385(9975):1305-14
pubmed: 25529582
Am J Hum Genet. 2015 Mar 5;96(3):498-506
pubmed: 25728775
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Blood. 2009 May 14;113(20):4866-74
pubmed: 19264921
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Clin Genet. 2019 Feb;95(2):253-261
pubmed: 28857140